Cargando…
Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
Autores principales: | Borgland, Stephanie L., Neyens, Drew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343116/ https://www.ncbi.nlm.nih.gov/pubmed/35705203 http://dx.doi.org/10.1503/jpn.220090 |
Ejemplares similares
-
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
por: Markopoulos, Athanasios, et al.
Publicado: (2022) -
Serotonergic Psychedelics in Neural Plasticity
por: Lukasiewicz, Kacper, et al.
Publicado: (2021) -
Complexities of psychedelics for therapeutic use in obesity and eating disorders
por: Reichelt, Amy
Publicado: (2022) -
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021) -
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)